Valer Gotea

The paper identifies RNA-binding proteins involved in suppressing latent splice site activation, with ALYREF interacting with U5 snRNA to regulate splicing accuracy.

The paper quantifies gene and isoform expression changes in metastatic melanoma compared to primary tumors, identifies distinct expression patterns linked to mutational subtypes, and highlights potential therapeutic targets.

This study identifies nucleolin as a novel regulator of splice site selection by directly interacting with initiator-tRNA, preventing latent splicing that would generate defective mRNAs.